- Usually announcements like this don't move the needle much but shares of Amyris (AMRS +15.6%) are up nicely this morning in apparent response to its collaboration with BASF.
- The company will use its synthetic biology and strain engineering platform to develop a microorganism capable of producing a BASF-targeted molecule.
- No financial terms are disclosed.
From other sites
at CNBC.com (Aug 1, 2012)
at CNBC.com (Sep 1, 2011)
at CNBC.com (Feb 7, 2011)
at CNBC.com (Jan 21, 2011)
at CNBC.com (Dec 8, 2010)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs